CIK 0000805928 · Large accelerated filer
Axogen, Inc.
Sign in to watch- Ticker
- AXGN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411301878
- Phone
- (386) 462-6817
- Business address
- 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
- Former names
- LECTEC CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $173,940
- in 1 filing, $174K under 10b5-1 plans
Net −$173,940. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-06 | Weiler Kathy Johnson Director | Grant or award | +10,653 | 10,653 | ||
| 2024-06-06 | Weiler Kathy Johnson Director | Grant or award · Employee Stock Option (right to purchase) | +18,248 | 18,248 | ||
| 2024-06-04 | Freitag Gregory Gene Director | Option exercise | +11,904 | 283,498 | ||
| 2024-06-04 | Freitag Gregory Gene Director | Option exercise · Restricted Stock Units | −11,904 | 0 | ||
| 2024-03-21 | Zaderej Karen L. CEO | Sale | −33,028 | $7.68 | $254K | 1,124,565 |
| 2024-03-21 | Zaderej Karen L. CEO | Sale | −3,086 | $7.68 | $24K | 1,133,979 |
| 2024-03-21 | Zaderej Karen L. CEO | Sale | −3,166 | $7.68 | $24K | 1,143,788 |
| 2024-03-21 | DeVinney Erick Wayne Chief Innovation Officer | Sale | −716 | $7.68 | $5K | 165,661 |
| 2024-03-21 | DeVinney Erick Wayne Chief Innovation Officer | Sale | −721 | $7.68 | $6K | 167,890 |
| 2024-03-21 | DeVinney Erick Wayne Chief Innovation Officer | Sale | −3,141 | $7.68 | $24K | 177,474 |
| 2024-03-21 | Scopelianos Angelo Chief R&D Officer | Sale | −5,251 | $7.68 | $40K | 52,999 |
| 2024-03-21 | Scopelianos Angelo Chief R&D Officer | Sale | −1,020 | $7.68 | $8K | 56,104 |
| 2024-03-21 | Scopelianos Angelo Chief R&D Officer | Option exercise | +2,500 | 58,604 | ||
| 2024-03-21 | Scopelianos Angelo Chief R&D Officer | Sale | −610 | $7.68 | $5K | 57,994 |
| 2024-03-21 | Donovan Michael Patrick VP Operations | Sale | −716 | $7.68 | $5K | 37,992 |
| 2024-03-21 | Donovan Michael Patrick VP Operations | Sale | −721 | $7.68 | $6K | 40,221 |
| 2024-03-21 | Donovan Michael Patrick VP Operations | Sale | −4,596 | $7.68 | $35K | 54,250 |
| 2024-03-16 | Zaderej Karen L. CEO | Option exercise | +84,847 | 1,157,593 | ||
| 2024-03-16 | Zaderej Karen L. CEO | Option exercise | +12,500 | 1,137,065 | ||
| 2024-03-16 | Zaderej Karen L. CEO | Option exercise | +12,975 | 1,146,954 |
Page 13 of 61 · 1,220 trades